F Andrási

497 total citations
25 papers, 427 citations indexed

About

F Andrási is a scholar working on Cellular and Molecular Neuroscience, Organic Chemistry and Molecular Biology. According to data from OpenAlex, F Andrási has authored 25 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 5 papers in Organic Chemistry and 5 papers in Molecular Biology. Recurrent topics in F Andrási's work include Neuroscience and Neuropharmacology Research (11 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Chemical Synthesis and Analysis (2 papers). F Andrási is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Chemical Synthesis and Analysis (2 papers). F Andrási collaborates with scholars based in Hungary and Czechia. F Andrási's co-authors include Pál Berzsenyi, István Tarnawa, Sándor Farkas, Ágnes Pataki, Franciska Erdő, Katalin Horváth, Péter Molnár, Sándor Sólyom, Sándor Farkas and László G. Hársing and has published in prestigious journals such as European Journal of Pharmacology, Pharmacological Research and Bioorganic & Medicinal Chemistry.

In The Last Decade

F Andrási

21 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F Andrási Hungary	11	338	230	54	53	52	25	427
Pál Berzsenyi Hungary	12	317 0.9×	224 1.0×	56 1.0×	55 1.0×	49 0.9×	19	451
Alex Haahr Gouliaev Denmark	5	143 0.4×	126 0.5×	41 0.8×	84 1.6×	35 0.7×	7	352
H. Shinozaki Japan	13	338 1.0×	240 1.0×	13 0.2×	52 1.0×	35 0.7×	25	440
Shigeo Watabe Japan	13	298 0.9×	238 1.0×	57 1.1×	16 0.3×	38 0.7×	25	418
Richard G. Boles United States	5	304 0.9×	261 1.1×	42 0.8×	45 0.8×	14 0.3×	8	461
M Quarum United States	6	404 1.2×	484 2.1×	19 0.4×	41 0.8×	20 0.4×	8	627
Dorota Matecka United States	13	580 1.7×	398 1.7×	67 1.2×	83 1.6×	13 0.3×	31	716
Nancy M. Gray United States	13	296 0.9×	321 1.4×	28 0.5×	81 1.5×	17 0.3×	17	464
Luc Peeters Belgium	12	307 0.9×	357 1.6×	35 0.6×	21 0.4×	32 0.6×	14	481
Werner Inderbitzin Switzerland	6	319 0.9×	210 0.9×	24 0.4×	17 0.3×	50 1.0×	8	359

Countries citing papers authored by F Andrási

Since Specialization

Citations

This map shows the geographic impact of F Andrási's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Andrási with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Andrási more than expected).

Fields of papers citing papers by F Andrási

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Andrási. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Andrási. The network helps show where F Andrási may publish in the future.

Co-authorship network of co-authors of F Andrási

This figure shows the co-authorship network connecting the top 25 collaborators of F Andrási. A scholar is included among the top collaborators of F Andrási based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Andrási. F Andrási is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tóth, Gábor, et al.. (2006). NMR spectroscopic structure elucidation of the products of the reaction of 3‐(3‐aryl‐3‐oxopropenyl)‐ chromen‐4‐ones with 1,2‐phenylenediamine. Magnetic Resonance in Chemistry. 44(9). 856–860. 3 indexed citations

Erdő, Franciska, Pál Berzsenyi, & F Andrási. (2005). The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia. Brain Research Bulletin. 66(1). 43–49. 28 indexed citations

Erdő, Franciska, et al.. (2005). Talampanel improves the functional deficit after transient focal cerebral ischemia in rats. A 30-day follow up study. Brain Research Bulletin. 68(4). 269–276. 27 indexed citations

Andrási, F. (2001). Search for antiulcer agents at IDR.. PubMed. 56 Suppl 1. S31–3. 1 indexed citations

Andrási, F. (2001). [The search for anti-ulcer agents at IDR].. PubMed. 71(1). 40–3.

Andrási, F. (2001). Talampanel. Drugs of the Future. 26(8). 754–754. 20 indexed citations

Sólyom, Sándor, et al.. (2000). Structural analogues of some highly active non-competitive AMPA antagonists. Bioorganic & Medicinal Chemistry Letters. 10(9). 899–902. 9 indexed citations

Sólyom, Sándor, Pál Berzsenyi, István Tarnawa, et al.. (2000). New non competitive AMPA antagonists. Bioorganic & Medicinal Chemistry. 8(8). 2127–2143. 52 indexed citations

Horváth, Katalin, et al.. (1992). Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone.. PubMed. 79(2). 153–61. 13 indexed citations

10.

Horváth, Katalin, et al.. (1992). Girisopam and GYKI 52 322 do not potentiate the anticolvulsant and antiaggressive effect of chlordiazepoxide in mice. Pharmacological Research. 25. 41–42. 2 indexed citations

11.

Tarnawa, István, et al.. (1992). Inhibition of hippocampal field potentials by GYKI 52466 in vitro and in vivo.. PubMed. 79(2). 163–9. 30 indexed citations

12.

Tarnawa, István, et al.. (1990). Reflex inhibitory action of a non-NMDA type excitatory amino acid antagonist, GYKI 52466.. PubMed. 75 Suppl. 277–8. 14 indexed citations

13.

Horváth, Katalin, et al.. (1990). Pharmacological effects of GYMI 52 895, a new selective dopamine uptake Inhibitor. European Journal of Pharmacology. 183(4). 1416–1417. 6 indexed citations

14.

Tarnawa, István, Sándor Farkas, Pál Berzsenyi, Ágnes Pataki, & F Andrási. (1989). Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466. European Journal of Pharmacology. 167(2). 193–199. 115 indexed citations

15.

Horváth, Katalin, et al.. (1989). A new psychoactive 5H-2,3-benzodiazepine with a unique spectrum of activity.. PubMed. 39(8). 894–9. 17 indexed citations

16.

Berzsenyi, Pál, István Tarnawa, Sándor Farkas, & F Andrási. (1988). Pharmacology of a new centrally acting muscle relaxant. Pharmacological Research Communications. 20. 139–140. 10 indexed citations

17.

Andrási, F, et al.. (1987). Neuropharmacology of a new psychotropic 2,3-benzodiazepine.. PubMed. 37(10). 1119–24. 13 indexed citations

18.

Horváth, Katalin, et al.. (1982). Morphine and [D-Met2,Pro5]enkephalinamide do not show specific neuroleptic activity. European Journal of Pharmacology. 80(4). 359–368. 6 indexed citations

19.

Andrási, F, et al.. (1971). ChemInform Abstract: PIPERAZINDERIVATE 3. MITT. DIAETHYLCARBAMYL‐ UND XANTHENDERIVATE. Chemischer Informationsdienst Organische Chemie. 2(49). 1 indexed citations

20.

Andrási, F, et al.. (1968). [Investigation of gastric ulcer inhibiting and secreto-inhibitory actions of thymoleptics in rats].. PubMed. 38(2). 159–65. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact